Chinese Medical Entrepreneurs annual meeting

The 8th Chinese Medical Entrepreneurs annual meeting was held in Beijing Economic and Development Area from Oct 28 to Nov 30. Over 1000 entrepreneurs, scientists and investors in medical areas from around the world attended. 

The meeting focused on innovation in the Chinese healthcare industry, and implementation of two centenary goals and the Chinese dream as prescribed by president Xi Jinping. It also created a JP Morgan healthcare industry investment meeting.

The meeting also discussed Chinese medical industry policies and trends. It analyzed the developing direction of the biological micro-molecules industry, clinical research and CRO, translational medicine, and bio-medical parks, and provided a multilevel, diversified and efficient communication platform for innovative enterprises and investment organizers.

JP Morgan healthcare industry investment meeting

The JP Morgan healthcare industry investment meeting was concerned with medical innovative projects presented in a road show platform format. It brought together investment projects and investors and was well received.

Listed Chinese medical enterprises competitiveness awards

The 8th competitiveness awards event for listed Chinese medical companies was recently held in the Beijing Economic and Development Area. It awarded the top 20 listed Chinese medical enterprises, top 10 medical listed enterprises in terms of value, and the top 10 R&D-invested listed medical enterprises. Besides giving awards the event included the opening ceremonies of Future Medicine-Huawei and the Chinese medical enterprises CSR alliance. It also provided a photographic exhibition of Chinese medical leaders. 

The Beijing Economic and Development Area is a technological innovative center in Beijing which houses over 600 enterprises in chemistry, bio-medicine, traditional Chinese medicine, and diagnostic reagents, and includes a medicine distribution area, nine Chinese National Engineering Research centers, 74 key laboratories and innovative company platforms. During the 12th Five-Year plan, its total industrial value rose by 12.5 percent and accounted for 50 percent of Beijing's bio-medical industries’ value.

Beijing E-Town International Investment & Development Co., Ltd (E-Town Capital) is a Stated-owned investment and financing company with the mission of promoting industrial upgrading and technological innovation in Beijing E-Town. To date, E-Town Capital has invested in over 110 projects, with a total investment of 24 billion yuan ($ 3.6 billion). Its parent fund controls 55 sub-funds, and participates in the management of more than 240 billion yuan（$36 billion）. E-Town Capital has gradually refined its financial services, including financial assurance, leasing and petty loans, upgraded its product systems and served the innovative development of small and medium-sized enterprises. E-Town Capital attended this meeting to create an entrepreneurial and innovative environment and empower industrial chain development.

Chinese 50 person healthcare executive committee forum 

During the same three days the first Chinese healthcare executive committee forum, consisting of 50 people, was established in Beijing. The general manager of E-Town Capital Wang Xiaobo was appointed to its executive committee.

China's 13th Five-Year Plan includes a Healthy China strategy. It is anticipated that healthcare industries during the period will number 100 thousand, which will be a huge opportunity for infusion of overseas capital.

The 50 person investment forum was established in Beijing on May 19 at the Bird's nest culture center. A meeting in August was then held to confirm the organization's structure, events' frequency and brand protection to lay a solid foundation for the development of the current forum.

The following fifteen leading executives attended the first meeting of the Chinese healthcare executive committee: the general manager of Legend Capital Cai Daqing, CITIC Securities Cheng Jie, the founder of Northern Light Venture Capital De Feng, the general manager of Warburg Pincus Fang Min, the general manager of Fountainvest Partners Lv Mingfang, the secretary general of Light China Li Hongyi, partner of eagle fund Tang Chuanlong, the general manager of E-Town Capital Wang Xiaobo, the president of JD capital medical fund Wu Qinggong, the CEO of HG capital Xu Xiaolin, partner of Marathon Venture Yang Ruirong, the general manager of Kehua Insight Venture Capital Yue Rong, the CEO of Sinopharm Capital Zhang Yi and the former CEO of CITICPE. 

The committee passed its regulations and chose its executive including the chairman and secretary general; it also confirmed that the first meeting of the Chinese healthcare industries 50 person investment forum will be on Dec 18.

In this time of an interlocked economy, the Chinese healthcare investment market will transform to adapt to market changes, and the healthcare industries' 50 person investment forum will grow into a leader in medical investment.